| Dr Rohit Gupta, MD | |
|
3401 N Broad St, Philadelphia, PA 19140-5103 | |
| (215) 707-5864 | |
| (215) 707-6867 |
| Full Name | Dr Rohit Gupta |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 15 Years |
| Location | 3401 N Broad St, Philadelphia, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427363654 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD456966 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Temple University Hospital | Philadelphia, PA | Hospital |
| Chestnut Hill Hospital | Philadelphia, PA | Hospital |
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Temple Faculty Practice Plan Inc | 0345588711 | 1063 |
News Archive
Because there is currently no laboratory test that can diagnose Parkinson's disease, it is practically impossible to detect those individuals who are in the earliest stages of the disease. As a result, Parkinson's disease can only be diagnosed by a clinical neurological examination based on findings suggestive of the disease.
Food and Drug Administration (FDA) is currently reviewing the combination of extended release (ER) niacin and laropiprant under the trademark Cordaptive (ER niacin/laropiprant). The CHMP recommendation does not apply to regulatory decisions by the FDA and no inferences should be made about pending FDA regulatory actions based on the recommendation of the CHMP.
In the August issue of Molecular & Cellular Proteomics, scientists provide the first large-scale identification of proteins that are overexpressed in chronic pancreatitis, an inflammatory condition of the pancreas that shares many features with pancreatic cancer.
When women under 50 develop breast cancer the disease tends to be more aggressive and less responsive to treatment than when it occurs in older women.
› Verified 9 days ago
| Entity Name | Temple Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942444088 PECOS PAC ID: 2062317233 Enrollment ID: O20040310000054 |
News Archive
Because there is currently no laboratory test that can diagnose Parkinson's disease, it is practically impossible to detect those individuals who are in the earliest stages of the disease. As a result, Parkinson's disease can only be diagnosed by a clinical neurological examination based on findings suggestive of the disease.
Food and Drug Administration (FDA) is currently reviewing the combination of extended release (ER) niacin and laropiprant under the trademark Cordaptive (ER niacin/laropiprant). The CHMP recommendation does not apply to regulatory decisions by the FDA and no inferences should be made about pending FDA regulatory actions based on the recommendation of the CHMP.
In the August issue of Molecular & Cellular Proteomics, scientists provide the first large-scale identification of proteins that are overexpressed in chronic pancreatitis, an inflammatory condition of the pancreas that shares many features with pancreatic cancer.
When women under 50 develop breast cancer the disease tends to be more aggressive and less responsive to treatment than when it occurs in older women.
› Verified 9 days ago
| Entity Name | Temple Faculty Practice Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881176949 PECOS PAC ID: 0345588711 Enrollment ID: O20190208002623 |
News Archive
Because there is currently no laboratory test that can diagnose Parkinson's disease, it is practically impossible to detect those individuals who are in the earliest stages of the disease. As a result, Parkinson's disease can only be diagnosed by a clinical neurological examination based on findings suggestive of the disease.
Food and Drug Administration (FDA) is currently reviewing the combination of extended release (ER) niacin and laropiprant under the trademark Cordaptive (ER niacin/laropiprant). The CHMP recommendation does not apply to regulatory decisions by the FDA and no inferences should be made about pending FDA regulatory actions based on the recommendation of the CHMP.
In the August issue of Molecular & Cellular Proteomics, scientists provide the first large-scale identification of proteins that are overexpressed in chronic pancreatitis, an inflammatory condition of the pancreas that shares many features with pancreatic cancer.
When women under 50 develop breast cancer the disease tends to be more aggressive and less responsive to treatment than when it occurs in older women.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rohit Gupta, MD 2450 W Hunting Park Ave, Philadelphia, PA 19129-1302 Ph: (215) 707-5864 | Dr Rohit Gupta, MD 3401 N Broad St, Philadelphia, PA 19140-5103 Ph: (215) 707-5864 |
News Archive
Because there is currently no laboratory test that can diagnose Parkinson's disease, it is practically impossible to detect those individuals who are in the earliest stages of the disease. As a result, Parkinson's disease can only be diagnosed by a clinical neurological examination based on findings suggestive of the disease.
Food and Drug Administration (FDA) is currently reviewing the combination of extended release (ER) niacin and laropiprant under the trademark Cordaptive (ER niacin/laropiprant). The CHMP recommendation does not apply to regulatory decisions by the FDA and no inferences should be made about pending FDA regulatory actions based on the recommendation of the CHMP.
In the August issue of Molecular & Cellular Proteomics, scientists provide the first large-scale identification of proteins that are overexpressed in chronic pancreatitis, an inflammatory condition of the pancreas that shares many features with pancreatic cancer.
When women under 50 develop breast cancer the disease tends to be more aggressive and less responsive to treatment than when it occurs in older women.
› Verified 9 days ago
Philippe Olivier Szapary, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3400 Civic Center Blvd, East Pavilion, 2nd Floor, Philadelphia, PA 19104 Phone: 215-615-4949 | |
Dr. Jamie L. Garfield, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-5864 Fax: 215-707-6867 | |
Maria Esther Escorcia De Leon, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3401 N Broad St, Philadelphia, PA 19140 Phone: 215-707-1622 Fax: 215-707-0943 | |
Cherag Daruwala, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2301 E Allegheny Ave, Suite 190b, Philadelphia, PA 19134 Phone: 215-926-3120 Fax: 215-926-3123 | |
Dr. Robert Burke, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 51 N 39th St, Philadelphia, PA 19104 Phone: 215-662-9436 Fax: 215-243-3208 | |
Eva Hassan Alsheik, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 219 N Broad St, 5th Floor, Philadelphia, PA 19107 Phone: 215-762-6071 | |
Dr. Jason Thomas Ackrivo, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3400 Spruce St, Philadelphia, PA 19104 Phone: 215-614-0871 |